DEKA Biosciences

Germantown, MD · Founded 2019 · Privately Held (backing)

Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases. DEKA Biosciences is based in Germantown, MD and was founded in 2019. It was valued at $36 million at its early-stage round in Feb 2023, the last priced event on record. It has raised $104 million across 2 recorded rounds; the latest was a $29.9 million early-stage round in Feb 2023.

PMV mark · valuation
$36.0M
Oct 2026
Priced at
its early-stage round
Feb 2023
Total raised
$104.2M
Last round
Early Stage VC
Feb 2023

Who backs DEKA Biosciences?

10 investors
InvestorType
Alexandria Venture InvestmentsOther
Echo Investment CapitalPE / buyout
Viva BioInnovatorOther
MPM BioImpactVenture capital
ATEM Capital—
Amana Investment Fund—
Atum Capital—
Leaps by Bayer—
Lumira Ventures—
Plains Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

DEKA Biosciences investors

10 investors are on record for DEKA Biosciences, including Alexandria Venture Investments, Echo Investment Capital, Viva BioInnovator and MPM BioImpact. The early-stage round in Feb 2023 drew 33 investors.

Free account
More of DEKA Biosciences with a free account
  • ·Watch DEKA Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like DEKA Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View